Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
Technology
History
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/c5/ee/ff/c5eeffe7-39e5-0244-76d3-05d164d35155/mza_12284675862809122241.jpg/600x600bb.jpg
In the Pipeline
Tyler Vaglivelo
2 episodes
1 day ago
This is a podcast about advancements in clinical trials as they emerge, before regulatory milestones or publication of associated data. The views expressed are my own, and I have no financial affiliations with the companies discussed, nor is this affiliated with any employer.
Show more...
Medicine
Health & Fitness
RSS
All content for In the Pipeline is the property of Tyler Vaglivelo and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This is a podcast about advancements in clinical trials as they emerge, before regulatory milestones or publication of associated data. The views expressed are my own, and I have no financial affiliations with the companies discussed, nor is this affiliated with any employer.
Show more...
Medicine
Health & Fitness
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/44151036/44151036-1754652290950-12b1e9a653ec8.jpg
In the Pipeline - Epigenetic Bonanza (10/19-11/1)
In the Pipeline
9 minutes 43 seconds
1 day ago
In the Pipeline - Epigenetic Bonanza (10/19-11/1)

The first episode of the relaunched podcast, focusing exclusively on oncology/hematology.

If you have any questions, please reach out at inthepipelinepodcast@gmail.com. Thank you for listening!

Topics:

Tango Therapeutics Reports Positive Data from Ongoing Phase 1/2 Study with Vopimetostat (TNG462) in Patients with MTAP-deleted Cancers

Halda Therapeutics Announces First-in-Human Results for HLD-0915, an Oral RIPTAC™ Therapeutic Demonstrating Encouraging Safety and Anti-Tumor Activity in Metastatic Castration-Resistance Prostate Cancer (mCRPC)

In the Pipeline
This is a podcast about advancements in clinical trials as they emerge, before regulatory milestones or publication of associated data. The views expressed are my own, and I have no financial affiliations with the companies discussed, nor is this affiliated with any employer.